OLIVETO JOSEPH (President and CEO) sold 12.5% of their position (43.50K shares) of MILESTONE PHARMACEUTICALS INC. on the open market
Open‑market sale worth $97.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/9/2026ACC: 0001437782-26-000002
DirectorOfficer· President and CEO
Since May 2019
-43.50K
Net shares
Net seller
$97.9K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
43.50K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
−500.00
Price / share
$2.25
Trade value
$1.13K
% of position
0.1%
1/7/2026
347.22K→346.72K
Common Shares
Direct
Shares
−43K
Price / share
$2.25
Trade value
$96.75K
% of position
12.4%
1/8/2026
346.72K→303.72K
Total
Net shares
−43.50K
Net value
-$97.88K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 1/7/2026 | S · Sale | −500.00 | $2.25 | $1.13K | 0.1% | 347.22K | 346.72K |
| Common Shares Direct | 1/8/2026 | S · Sale | −43K | $2.25 | $96.75K | 12.4% | 346.72K | 303.72K |
| Total | −43.50K | -$97.88K | ||||||
Derivative Transactions0
No derivative transactions reported